{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:08:40Z","timestamp":1790395720300,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.antiviral.2019.104579","type":"journal-article","created":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T16:31:21Z","timestamp":1565109081000},"page":"104579","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Investigation of hepatitis B virus (HBV) rtS78T\/sC69* mutation in a large cohort of chronic HBV-infected patients with nucleoside\/nucleotide analogue treatment"],"prefix":"10.1016","volume":"170","author":[{"given":"Dan","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongjuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lujie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bixia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2019.104579_bib1","first-page":"2159","article-title":"Guideline on prevention and treatment of chronic hepatitis B in China","volume":"120","author":"Chinese Society of Hepatology","year":"2007","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.antiviral.2019.104579_bib2","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jhep.2015.03.020","article-title":"Characterization of novel entecavir resistance mutations","volume":"63","author":"Hayashi","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2019.104579_bib3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jcv.2012.02.003","article-title":"The rtL229 substitutions in the reverse transcriptase region of hepatitis B virus (HBV) polymerase are potentially associated with lamivudine resistance as a compensatory mutation","volume":"54","author":"Ji","year":"2012","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2019.104579_bib4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3851\/IMP3280","article-title":"Monitoring of serum HBV RNA, HBcrAg, HBsAg and anti-HBc levels in patients during long-term nucleoside\/nucleotide analogue therapy","volume":"24","author":"Liao","year":"2019","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2019.104579_bib5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.5009\/gnl15562","article-title":"Management of antiviral resistance in chronic hepatitis B","volume":"11","author":"Lim","year":"2017","journal-title":"Gut Liver"},{"key":"10.1016\/j.antiviral.2019.104579_bib6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.antiviral.2019.02.012","article-title":"Prevalence of the entecavir-resistance-inducing mutation rtA186T in a large cohort of Chinese hepatitis B virus patients","volume":"164","author":"Liu","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104579_bib7","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/jvh.12298","article-title":"The rtA181S mutation of hepatitis B virus primarily confers resistance to adefovirdipivoxil","volume":"22","author":"Liu","year":"2015","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.antiviral.2019.104579_bib8","doi-asserted-by":"crossref","DOI":"10.3851\/IMP3305","article-title":"Molecular cloning and phenotypic analysis of drug-resistance mutants with relevant S-region variants of HBV for a patient during 189-month anti-HBV treatment","author":"Liu","year":"2019","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2019.104579_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3851\/IMP2971","article-title":"Increased occurrence of mutant rtI233V of HBV in patients receiving adefovir therapy","volume":"21","author":"Liu","year":"2016","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2019.104579_bib10","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1080\/22221751.2019.1584018","article-title":"Hepatitis B virus mutation pattern rtL180M+A181C+M204V may contribute to entecavir resistance in clinical practice","volume":"8","author":"Liu","year":"2019","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.antiviral.2019.104579_bib11","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: update 2009","volume":"50","author":"Lok","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2019.104579_bib12","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/hep.21698","article-title":"Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management","volume":"46","author":"Lok","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2019.104579_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2893.2010.01282.x","article-title":"Diversity of hepatitis B virus infecting Malaysian candidate blood donors is driven by viral and host factors","volume":"18","author":"Meldal","year":"2011","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.antiviral.2019.104579_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2019.02.006","article-title":"Identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patients","author":"Park","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2019.104579_bib15","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.jhep.2017.07.011","article-title":"How viral genetic variants and genotypes influence disease and treatment outcome of chronic hepatitis B. Time for an individualised approach?","volume":"67","author":"Rajoriya","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2019.104579_bib16","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1365-2893.2009.01254.x","article-title":"Hepatitis B virus genotype and basal core promoter\/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis","volume":"17","author":"Ren","year":"2010","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.antiviral.2019.104579_bib17","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jhep.2017.03.027","article-title":"Selection of the highly replicative and partially multidrug resistant rtS78T HBV polymerase mutation during TDF-ETV combination therapy","volume":"67","author":"Shirvani-Dastgerdi","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2019.104579_bib18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2893.2012.01638.x","article-title":"Hepatitis B virus wild-type and rtN236T populations show similar early HBV DNA decline in adefovir refractory patients on a tenofovir-based regimen","volume":"20","author":"Svarovskaia","year":"2013","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.antiviral.2019.104579_bib19","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jhep.2016.01.027","article-title":"Overview of hepatitis B viral replication and genetic variability","volume":"64","author":"Tong","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2019.104579_bib20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1053\/j.gastro.2008.09.068","article-title":"In vitro characterization of viral fitness of therapy-resistant hepatitis B variants","volume":"136","author":"Villet","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2019.104579_bib21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/hep.22295","article-title":"The antiviral drug selected hepatitis B virus rtA181T\/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound","volume":"48","author":"Warner","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2019.104579_bib22","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jhep.2016.09.005","article-title":"Effects of amino acid substitutions in hepatitis B virus surface protein on virion secretion, antigenicity, HBsAg and viral DNA","volume":"66","author":"Xiang","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2019.104579_bib23","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1038\/emi.2017.2","article-title":"Clinical features and viral quasispecies characteristics associated with infection by the hepatitis B virus G145R immune escape mutant","volume":"6","author":"Xue","year":"2017","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.antiviral.2019.104579_bib24","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2002.34740","article-title":"Resistance surveillance in chronic hepatitis B patients treated with adefovirdipivoxil for up to 60 weeks","volume":"36","author":"Yang","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2019.104579_bib25","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3851\/IMP1552","article-title":"Development of HBV S gene mutants in chronic hepatitis B patients receiving nucleotide\/nucleoside analogue therapy","volume":"15","author":"Yeh","year":"2010","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2019.104579_bib26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.virusres.2018.07.021","article-title":"Comparison of replication competence of wild-type and lamivudine-resistant hepatitis B virus isolates from a chronic hepatitis B patient","volume":"255","author":"Zhang","year":"2018","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2019.104579_bib27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.antiviral.2018.04.003","article-title":"Hepatitis B virus rtA181T\/sW172non-stop mutation may increase resistance fold to adefovir- and entecavir-resistant mutants compared to rtA181T\/sW172* mutation","volume":"154","author":"Zhao","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104579_bib28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1055\/s-2006-939759","article-title":"In vitro models for studying hepatitis B virus drug resistance","volume":"26","author":"Zoulim","year":"2006","journal-title":"Semin. Liver Dis."},{"issue":"S1","key":"10.1016\/j.antiviral.2019.104579_bib30","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/liv.12069","article-title":"Optimal management of chronic hepatitis B patients with treatment failure and antiviral drug resistance","volume":"33","author":"Zoulim","year":"2013","journal-title":"Liver Int."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219302396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219302396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:31:07Z","timestamp":1759062667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219302396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":29,"alternative-id":["S0166354219302396"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104579","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of hepatitis B virus (HBV) rtS78T\/sC69* mutation in a large cohort of chronic HBV-infected patients with nucleoside\/nucleotide analogue treatment","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104579","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104579"}}